Concepedia

Thorsten Blesken

TB

Statistics

Publications

6

Citations

2K

H-Index

6

Active since

1996

Affiliations

Novartis (Switzerland)(Current)

Lindenhofspital

Thorsten Blesken is an author at Novartis (Switzerland) specializing in allergy, venom allergy, and life sciences.

Publications per year

1996–1998

6

Publications

6

Role of interleukin 10 in specific immunotherapy.

Cezmi A. Akdiş, Thorsten Blesken, Mübeccel Akdiş et al. · Journal of Clinical Investigation · 1998 · 971 citations · Full text

, , +17

Successful immunotherapy with T-cell epitope peptides of bee venom phospholipase A2 induces specific T-cell anergy in patients allergic to bee venom☆☆☆★★★

Ulrich Müller, Cezmi A. Akdiş, Michael Fricker et al. · Journal of Allergy and Clinical Immunology · 1998 · 456 citations · Full text

, , +16

Epitope-specific T cell tolerance to phospholipase A2 in bee venom immunotherapy and recovery by IL-2 and IL-15 in vitro.

Cezmi A. Akdiş, Mübeccel Akdiş, Thorsten Blesken et al. · Journal of Clinical Investigation · 1996 · 312 citations · Full text

, , +16

Differential regulation of human T cell cytokine patterns and IgE and IgG4 responses by conformational antigen variants

Cezmi A. Akdiş, Thorsten Blesken, Daniel Wymann et al. · European Journal of Immunology · 1998 · 97 citations

, , +17

Induction and differential regulation of bee venom phospholipase A2–specific human IgE and IgG4 antibodies in vitro requires allergen-specific and nonspecific activation of T and B cells

Cezmi A. Akdiş, Thorsten Blesken, Mübeccel Akdis et al. · Journal of Allergy and Clinical Immunology · 1997 · 67 citations

, , +14

1–5 of 6